Vikas Gupta, CEO of OmniScience Capital, has cautioned investors to limit exposure to IT and pharmaceutical stocks due to high valuations and AI-related uncertainties. Amidst geopolitical tensions between the US and Iran keeping oil prices elevated, he suggests a defensive shift toward the banking and power sectors, which he believes offer better value in a high-inflation environment.
Vikas Gupta, CEO and Chief Investment Strategist at OmniScience Capital, has raised concerns about the valuation of the technology and pharmaceutical sectors. In a recent analysis, he advised investors to exercise caution with these segments, citing that current market prices may not fully account for the uncertainties surrounding the long-term earnings impact of artificial intelligence. For many retail investors, these sectors have been primary growth engines, but Gupta believes the risk-reward balance has shifted.
Geopolitical Risks and Inflationary Pressure
The cautious stance is largely driven by the ongoing geopolitical friction between the US and Iran. This conflict has emerged as a key risk factor for the global economy in 2026, threatening to keep crude oil prices elevated. Persistent, high energy costs tend to fuel inflation, which creates a challenging environment for central banks to lower interest rates. Higher interest rates for an extended period typically weigh on growth-sensitive sectors like technology, where future earnings potential is a major component of current valuations.
Moving Toward Defensive Sectors
To navigate this environment, Gupta advocates for a rotation into defensive sectors, specifically highlighting banking and power. He views these areas as currently undervalued, providing a potential buffer against broader market volatility. Banks often benefit from stable credit demand and margin management in varying economic cycles, while the power sector offers defensive characteristics driven by steady infrastructure requirements.
While sectors like textiles and chemicals have gained attention due to global supply chain realignment strategies—often referred to as the China+1 approach—Gupta noted that current valuations in these industries may limit the potential for gains. He emphasizes a disciplined, framework-based investment approach that prioritizes companies with strong balance sheets and established competitive advantages over sectors driven primarily by market hype.
IPO Discipline and Market Outlook
Addressing the ongoing wave of initial public offerings in India, Gupta urged investors to maintain discipline. He noted that while the National Stock Exchange and the broader Indian economy show strong long-term potential, the rush to participate in every listing can be risky. He suggested that liquidity from domestic mutual funds and investment plans helps sustain these listings, but investors often fare better by waiting for price corrections rather than participating in the initial listing frenzy.
The primary monitorable for investors in the coming months will be the trajectory of oil prices and the resulting impact on corporate profit margins. Companies with limited pricing power may struggle to pass on higher fuel and logistics costs to consumers, potentially pressuring bottom-line growth. Investors may track how these macro pressures influence quarterly earnings reports and whether valuations in the tech and pharma sectors align more closely with their long-term growth fundamentals.